JCA-directed evidence generation planning: First webinar successfully conducted - register now for the second session!!

Many thanks to all the participants who joined our webinar on ‘How to do early strategic evidence generation planning under the new common EU-HTA regulation?’. A recording of yesterday's session and a copy of the slides presented can be provided upon request.

 

JCA on oncology and ATMPs is less than 12 months away, and the expected timetable for the publication of the implementing acts of the EU HTA Regulation has only recently been updated. Therefore, we are pleased to invite you to our upcoming 2nd session

WEBINAR 2: How to plan and support the JCA dossier development?

§  For health technology developers who plan to launch within less than 2 years.

WEBINAR 2: On March 6th (Wednesday): 16:00 – 17:30 pm (CET)


If you have any questions or are interested in a customized workshop tailored to your business case, please do not hesitate to contact us via nils.picker@gipam-health.com.


More Articles

Previous
Previous

GIPAM overcompensates its carbon emissions by 4000%!

Next
Next

Join our Webinar series on JCA-directed evidence generation planning!